Skip to main content

Kate Bingham

Dame Kate Bingham served as the Chair of the UK Vaccine Taskforce, steering a team of experts to deliver the world’s fastest Covid-19 vaccination programme. She is a Managing Partner at SV Health Investors, where she co-leads SV’s biotech franchise. SV’s investments have resulted in the launch of twenty drugs for inflammatory and autoimmune disease, blindness and cancer. Kate is a board member of the Francis Crick Institute and helped launch the Dementia Discovery Fund – the largest fund ever to develop treatments for the disease.

Books by Kate Bingham

Sign up to our newsletter

Sign up to our newsletters to find out more about our latest books and offers, straight to your inbox.
Select mailing lists